Turn $1000 into $750K with These Coins: Catzilla Coin Tops the List with Over 10,000% Potential!
Cassava Sciences’ stock craters after Alzheimer’s disease trial fails to meet its goals
The biotech says it will discontinue a second trial but will still offer full analyses of the data.